As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS ...

Dementia affected an estimated ... Dr Gourlay said the new drug is close to proving it can deliver just that. While a drug for Alzheimer's has been marketed for 20 years as a 'memory booster ...

With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

Genetic differences that contribute to how long a person will live and their risk of Alzheimer's disease have been identified ...

19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease ... dementia, according to a new ...

Individuals who suffer head trauma from sports, accidents, or other causes often go on to develop neurodegenerative diseases ...

The study also integrates drug databases ... New Brain Mapping ... brain that are hallmarks of Alzheimer's disease up to 20 years before the earliest symptoms of dementia ...